BioVaxys Technology Corp. (CSE:BIOV)
Canada · Delayed Price · Currency is CAD 0.0550
-0.0050 (-8.33%)
Apr 10, 2026, 11:23 AM EST
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 2.43 million as of April 10, 2026. Its market cap has decreased by -84.66% in one year.
Market Cap
2.43M
Enterprise Value
2.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 2.43M, a decrease of -91.04%. That is a compound annual growth rate of -35.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 2.43M | -75.00% |
| Dec 31, 2025 | 9.70M | -41.13% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaTher Holdings | 5.92M |
| Kane Biotech | 5.46M |
| Restart Life Sciences | 5.33M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| ASEP Medical Holdings | 3.45M |
| Cytophage Technologies | 3.38M |
| Algernon Health | 2.71M |